Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tellus BioVentures is a biotechnology investment fund that specializes in early-stage innovation and company formation. Based in the life sciences sector, they focus on uncovering and accelerating promising therapeutics for patients with unmet medical needs. The firm primarily invests at the Seed stage and participates in Series A rounds, providing essential resources and expertise to their portfolio companies.
Tellus BioVentures invests in private biotech ventures at the Seed stage, often acting as the lead or sole investor. They also participate in Series A investments and are known for launching de novo companies to advance significant innovations. Their support includes management assistance and development expertise to help companies reach critical milestones.
Tellus BioVentures has backed companies developing extracellular vesicle therapy for rare diseases, monoclonal antibody therapeutics for autoimmune diseases, and novel methods for in vivo cell-specific gene delivery. Their portfolio also includes firms advancing antibody-drug conjugate (ADC) therapeutics and next-generation T-cell therapies.
Submit your pitch through their website's contact form for consideration.
Yes, Tellus BioVentures often acts as the lead or sole investor in Seed stage investments.
They participate in Series A investments, indicating a willingness to support their portfolio companies in subsequent funding rounds.
Tellus BioVentures not only invests in existing companies but also launches and funds de novo companies that may lack necessary resources for development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.